Category Archives: Genomics

New! MA student and genetic counsellor Alex Meyer shares her experience about 1st year of Bioethics & Society programme

MA student and genetic counsellor Alex Meyer talks about her experience as a MA student in Bioethics & Society at King’s College London, and about her career plans after the MA,  in this new interview: Applications for the Bioethics & … Continue reading

Posted in Bioethics, Careers, Genomics | Tagged , | Leave a comment

March 18th SSHM Seminar with Professor Christoph Rehmann-Sutter: “A ‘lived’ genome?”

Where: K.6.63 King’s Building Strand Campus When: 18/03/2015 (13:00-14:30) Christoph Rehmann-Sutter is Professor of Theory and Ethics in the Life Sciences, Institute for History of Medicine and Science Studies, University of Lübeck, Germany and visiting Professor at SSHM. His work focuses … Continue reading

Posted in Bioeconomy, Bioethics, Genomics | Tagged , , | Leave a comment

Should People have a Right to know their own Genome? SSHM Professor Barbara Prainsack at Conway Hall, March 8th

When: Sun 8 Mar 2015, 11:00 Where: Conway Hall, 25 Red Lion Square, WC1R 4RL Our society produces unprecedented amounts of data today. Some of this data will be used in the health domain. Also the creation of genetic data has become … Continue reading

Posted in Bioethics, Careers, Genomics, Health Policy | Tagged , | Leave a comment

Next SSHM Seminar, February 4th: Dr Silvia Camporesi on “Stop this talk of new eugenics! Reframing the discourse around reproductive genetic technologies”

The Department of Social Science, Health and Medicine is  delighted to announce the next event in our SSHM Seminar Series event. Please mark your calendars to hear Dr Silvia Camporesi (Department of SSHM, KCL) speak about her work on reproductive genetic technologies. Her … Continue reading

Posted in Bioethics, Careers, Genomics, Health Policy, Medical Humanities | Tagged , , | Leave a comment

Clinical Integration of Next Generation Sequencing in patient care: experts tackle three key policy areas

As techniques such as next generation sequencing, which determines the precise order of the nucleotides that make up DNA, are used in patient diagnosis and treatment, three critical policy areas remain ill-defined: Regulation by the U.S. Food and Drug Administration … Continue reading

Posted in Bioeconomy, Genomics, Health Policy | Tagged , | Leave a comment